Chemotherapy is very good at killing most of a tumor. It’s the cells that survive that cause the real trouble later — and new research from The Wistar Institute suggests some of those survivors may be using a common dietary sugar as a messenger to help their neighbors break free and spread.
The study, led by postdoctoral fellow Dr. Aidan Cole and senior author Dr. Katherine Aird, was published in Nature Aging and focused on high-grade serous ovarian cancer, the most common and aggressive form of the disease.
Key Takeaways
- Cancer cells that survive chemotherapy don’t necessarily die off — some enter a dormant-but-active state called senescence, where they stop dividing but keep releasing signaling molecules.
- Researchers found these surviving cells release fructose as one of those signals, which suppresses cholesterol in neighboring tumor cells.
- Lower cholesterol weakens how well cells stick together, making it easier for tumor cells to detach and spread — a process called metastasis, which accounts for roughly 90% of ovarian cancer deaths.
- This is early-stage laboratory research, not yet tested in patients, and the researchers are careful to say they can’t yet call the effect universal across cancer types.
Why Cells That Survive Chemo Still Matter
Ovarian cancer is treated almost universally with platinum-based chemotherapy, and most patients initially respond well. The problem is what happens afterward: the disease recurs in most patients and almost always spreads throughout the abdominal cavity. Prior research had already suggested that cancer cells not killed by chemotherapy — cells that enter a “senescent” state, meaning they stop dividing but remain biologically active — play a role in that later recurrence and spread, in part by releasing a complex mix of signaling molecules to nearby cells. What wasn’t clear was exactly which molecules mattered, or how.
What the Researchers Found
Using a large-scale genetic screening technique called a CRISPR screen, the team discovered that fructose released by these surviving cells suppresses cholesterol production in neighboring tumor cells. Cholesterol plays an important structural role in how cells stick to one another, similar to a biological glue — so when nearby cells have less of it, they become more prone to detaching from the tumor and migrating elsewhere in the body. “Some cancer cells that survive chemotherapy aren’t dividing anymore, but they’re still biologically active,” Dr. Cole said. “Instead, they continue to release molecules that send signals to nearby cells. Our study is among the first to show that a nutrient — in this case, fructose — can act as one of those signals,” rather than simply functioning as fuel for growth.
A Question the Findings Raise, Not an Answer
Because the mechanism runs through cholesterol, the findings raise an open question the researchers themselves haven’t tested yet: whether combining cholesterol-lowering drugs with chemotherapy might help. Dr. Aird noted this is a particularly relevant question given that ovarian cancer is most common in postmenopausal women, many of whom are already taking statins for cardiovascular reasons. It’s worth being precise here — this is a hypothesis worth investigating, not evidence that statins currently help or harm cancer outcomes, and the researchers have not tested this effect in patients.
What’s Still Unknown
This research was done in the lab, and the team hasn’t yet confirmed the mechanism holds true in living organisms or actual patients. The researchers also aren’t claiming this pattern applies broadly yet: while they suspect other cancers that spread within the torso — including pancreatic, colon, and liver cancer — might behave similarly, given that these cancers share some biological similarities with ovarian cancer’s spread pattern, Dr. Aird was direct about the limits of current evidence: “We can’t call it universal yet.” Follow-up experiments testing whether the same fructose-signaling pathway shows up in other cancer types are already underway.
Source: Cole, A.R., et al. (2026). The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming. Nature Aging. DOI: 10.1038/s43587-026-01172-5.